Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 27,003 | 27,847 | 17,097 | 14,649 | 1,761 |
| Operating Income | -27,003 | -27,847 | -17,097 | -14,649 | -1,761 |
| Interest Expense | 604 | 1,170 | 1,170 | 1,017 | 1,476 |
| Other Income | 1,864 | 88 | 645 | -2,663 | 92 |
| Pre-tax Income | -25,743 | -28,930 | -17,622 | -18,329 | -3,145 |
| Income Tax | 2 | 36 | N/A | N/A | N/A |
| Net Income Continuous | -25,744 | -28,966 | -17,622 | -18,329 | -3,145 |
| Minority Interests | 242 | 745 | 485 | 298 | 11 |
| Net Income | $-25,503 | $-28,221 | $-17,138 | $-18,031 | $-3,135 |
| EPS Basic Total Ops | -0.76 | -1.17 | -0.91 | -1.47 | -0.24 |
| EPS Basic Continuous Ops | -0.76 | -1.17 | -0.91 | -1.47 | N/A |
| EPS Diluted Total Ops | -0.76 | -1.17 | -0.91 | -1.47 | -0.24 |
| EPS Diluted Continuous Ops | -0.76 | -1.17 | -0.91 | -1.47 | N/A |
| EBITDA(a) | $-24,967 | $-27,604 | $-16,310 | $-17,224 | $-1,578 |